U.S. MarketsIMPORTANTOctober 21 at 07:30 AM

Abbott Laboratories (ABT) Q3 2026 (USD): Adj. EPS 1.42 (exp. 1.42), Revenue 13.0bln (exp. 12.99bln)

StockNow breaking-news AI analysis

Abbott reported Q3 adjusted EPS of $1.42 and revenue of $13.0 billion, and provided Q4 and FY adjusted EPS outlook ranges.

News detail

Outlook Q4 adj. EPS 1.62-1.67 (exp. 1.64). FY adj. EPS 5.50-5.55 (exp. 5.51).

1 stocks

ABTAbbott Laboratories$102.41Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Pakistan Army Chief Munir, in his meeting with Iranian officials, brought with him the "final warning" from the United States, which calls on Iran to submit to the American demand for concessions on the nuclear issue before taking any other steps

Iran's Secretary of Supreme National Security Council Rezaei informed Pakistan's Army Chief Munir of Iran's explicit rejection of the American demands, reports Al Hadath

Iran's Foreign Minister Araghchi says they are ready for diplomacy, but will defend themselves, FT reports; US has shown no willingness to reach an understanding, little reason to expect progress now